STOCK TITAN

PolyPid: 9.99% blocker restricts warrant exercise

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

For PolyPid Ltd. (PYPD), Rosalind Master Fund L.P., Rosalind Advisors, Inc., Steven Salamon, the advisor’s portfolio manager, and Gilad Aharon, its portfolio manager and member, reported ownership in an amended Schedule 13G. The cover pages list 4,735,367 shares and 9.6%, including 4,558,356 shares issuable upon warrant exercise.

Item 4 states that Rosalind Master Fund L.P. may have been deemed to beneficially own 177,011 common shares, approximately 0.84%. It says the warrants could not be exercised as of September 30, 2026, because a 9.99% blocker applies. The cover-page total includes warrant shares without giving effect to that blocker; Rosalind Advisors, Inc. and Steven Salamon disclaim beneficial ownership of the shares.

Cover-page reported shares 4,735,367 shares The cover pages report this aggregate, including shares issuable upon warrant exercise.
Warrant shares issuable 4,558,356 shares Included in the cover-page aggregate; the filing states the warrants could not be exercised as of September 30, 2026, due to the blocker.
Common shares 177,011 shares Item 4 says Rosalind Master Fund L.P. may have been deemed to beneficially own this amount.
Cover-page percentage of class 9.6% Percentage reported on the cover pages alongside the 4,735,367-share aggregate.
Item 4 percentage Approximately 0.84% Item 4’s stated percentage for 177,011 common shares.
Common shares outstanding 21,125,704 shares Outstanding as of September 30, 2026, according to the filing.
Warrant blocker 9.99% The blocker restricts exercise where it would cause the holder to exceed this beneficial-ownership level.
beneficial ownership regulatory
"may have been deemed to have the beneficial ownership of 177,011 shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
blocker provision regulatory
"blocker provision under which the holder thereof does not have the right to exercise"
shared voting power regulatory
"Shared Voting Power 4,735,367.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
dispositive power regulatory
"Shared Dispositive Power 4,735,367.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PYPD shares did the Schedule 13G/A report?

The cover pages list 4,735,367 shares, including 4,558,356 shares issuable upon warrant exercise. Item 4 separately states that Rosalind Master Fund L.P. may have been deemed to beneficially own 177,011 common shares, approximately 0.84%.

Who does the PYPD Schedule 13G/A identify as a beneficial owner?

The filing states that Rosalind Master Fund L.P. may have been deemed to beneficially own 177,011 common shares. Rosalind Advisors, Inc. and Steven Salamon, the advisor’s portfolio manager, may also have been deemed beneficial owners of shares held by the fund, but they disclaim beneficial ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





M8001Q126

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: This percentage is calculated based upon 21,125,704 Ordinary shares of the Issuers common stock outstanding as of September 30, 2026, based on the 6K issued by Polypid Ltd on November 11, 2026. However, as more fully described in Item 4, the securities reported in rows 6, 8 and 9 show the number of shares of Common Stock that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows 6, 8 and 9. (6) 177,011 shares of Common Stock 4,558,356 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 177,011 shares of Common Stock 4,558,356 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 177,011 shares of Common Stock 4,558,356 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 177,011 shares of Common Stock 4,558,356 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G



Rosalind Advisors, Inc.
Signature:Steven Salamon
Name/Title:President
Date:11/13/2026
SALAMON STEVEN A J
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:11/13/2026
Aharon Gil
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:11/13/2026
Rosalind Master Fund L.P.
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:11/13/2026

Keep reading